Filing Details

SEC Filing Details

Document Details

Form
Filing Date
Feb 10, 2021
Document Date
Feb 5, 2021
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Aclaris Therapeutics, Inc.
Issuer
Aclaris Therapeutics, Inc.
Filer
Foresite Capital Management III, LLC